Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip

Inclusion Criteria: * Is male or female ≥ 40 years of age * If a participant in the previous MEL3-12-02 study, completed the study and did not discontinue for lack of efficacy or safety * Has a diagnosis of OA of the hip or knee with ongoing knee and/or articular hip pain * Chronic user of nonsteroidal anti-inflammatory drugs (NSAIDs) and/or acetaminophen for OA pain * If female and of childbearing potential, is nonlactating and nonpregnant Exclusion Criteria: * History of allergic reaction or clinically significant intolerance to acetaminophen, aspirin, or any NSAIDs, including meloxicam * Requires continuous use of opioid or opioid combination products to control OA pain of the knee or hip * Clinically significant unstable cardiac, respiratory, neurological, immunological, hematological, or renal disease * Significant difficulties swallowing capsules or unable to tolerate oral medication * Has received any investigational drug (except Meloxicam SoluMatrix Capsules), device, or therapy within 30 days before Screening